Non-Coding RNAs in Oral Cancer: Emerging Roles and Clinical Applications
Cancers · 25.07.2023 · 15 (15) · 3752
DOI: 10.3390/cancers15153752 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 25.07.2023. Verfasst von Saurabh Dey und 6 weiteren Autor:innen. Beteiligte Einrichtung: Cancer and Translational Research Centre, Dr. D. Y. Patil Biotechnology and Bioinformatics Institute, Dr. D. Y. Patil Vidyapeeth (DPU), Pimpri 411033…. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 327 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Department of Biotechnology, Ramalingaswami Re-entry fellowship, Department of Biotechnology, Govt. of India to S. Sur, Intramural Grants, Dr. D. Y. Patil Vidyapeeth (DPU), Pimpri, Pune, India to S. Basu.
Abstract (Originalsprache)
Oral cancer (OC) is among the most prevalent cancers in the world. Certain geographical areas are disproportionately affected by OC cases due to the regional differences in dietary habits, tobacco and alcohol consumption. However, conventional therapeutic methods do not yield satisfying treatment outcomes. Thus, there is an urgent need to understand the disease process and to develop diagnostic and therapeutic strategies for OC. In this review, we discuss the role of various types of ncRNAs in OC, and their promising clinical implications as prognostic or diagnostic markers and therapeutic targets. MicroRNA (miRNA), long ncRNA (lncRNA), circular RNA (circRNA), PIWI-interacting RNA (piRNA), and small nucleolar RNA (snoRNA) are the major ncRNA types whose involvement in OC are emerging. Dysregulated expression of ncRNAs, particularly miRNAs, lncRNAs, and circRNAs, are linked with the initiation, progression, as well as therapy resistance of OC via modulation in a series of cellular pathways through epigenetic, transcriptional, post-transcriptional, and translational modifications. Differential expressions of miRNAs and lncRNAs in blood, saliva or extracellular vesicles have indicated potential diagnostic and prognostic importance. In this review, we have summarized all the promising aspects of ncRNAs in the management of OC.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Cancer and Translational Research Centre, Dr. D. Y. Patil Biotechnology and Bioinformatics Institute, Dr. D. Y. Patil Vidyapeeth (DPU), Pimpri 411033, India.
ORCID-Profile: Saurabh Dey, Bini Biswas, Jayanta K Pal, Soumya Basu, Subhayan Sur
Förderung
- Department of Biotechnology
- Ramalingaswami Re-entry fellowship, Department of Biotechnology, Govt. of India to S. Sur
- Intramural Grants, Dr. D. Y. Patil Vidyapeeth (DPU), Pimpri, Pune, India to S. Basu
Zitieren
APA
Dey, S., Biswas, B., Manoj Appadan, A., Shah, J., Pal, J. K., Basu, S., & Sur, S. (2023). Non-Coding RNAs in Oral Cancer: Emerging Roles and Clinical Applications. Cancers, 15(15), 3752. https://doi.org/10.3390/cancers15153752
Vancouver
Dey S, Biswas B, Manoj Appadan A, Shah J, Pal JK, Basu S, et al. Non-Coding RNAs in Oral Cancer: Emerging Roles and Clinical Applications. Cancers. 2023;15(15):3752. doi:10.3390/cancers15153752
BibTeX
@article{Dey2023,
author = {Dey, Saurabh and Biswas, Bini and Manoj Appadan, Angela and Shah, Jaladhi and Pal, Jayanta K and Basu, Soumya and Sur, Subhayan},
title = {Non-Coding RNAs in Oral Cancer: Emerging Roles and Clinical Applications},
journal = {Cancers},
year = {2023},
volume = {15},
number = {15},
pages = {3752},
doi = {10.3390/cancers15153752}
}
EUVIMED